000 | 01033nam a2200265 a 4500 | ||
---|---|---|---|
001 | 000676276 | ||
005 | 20170516142249.0 | ||
008 | 090729s1997 ||||||||r|||||000|0|eng|d | ||
020 | _a0-7923-8718-X | ||
041 | 0 | _aeng | |
245 | 0 | 0 |
_aTrends in inflammatory bowel disease therapy 1996 / _cAxcan Pharma, Inc.; edited by R.S. McLeod [et al.]. |
260 |
_aDordrecht [etc.] : _bKluwer Academic Publishers, _c1997. |
||
300 |
_axvi, 292 p. : _bill. ; _c24 cm. |
||
500 | _a"The proceedings of a symposium organised by AXCAN PHARMA, held in Ottawa, June 12-15, 1996" | ||
504 | _aIncludes bibliographical references and index | ||
650 | 1 | 4 |
_aInflammatory bowel diseases _xCongresses |
650 | 1 | 4 |
_aInflammatory Bowel Diseases _xtherapy _xcongresses |
650 | 1 | 4 |
_aCrohn Disease _xtherapy _xcongresses |
650 | 1 | 4 |
_aColitis, Ulcerative _xtherapy _xcongresses |
700 | 1 |
_aMcLeod, Robin S. _eedt |
|
700 | 1 |
_aMartin, F. _eedt _91630 |
|
700 | 1 |
_aSutherland, L.R. _eedt |
|
700 | 1 |
_aWallace, J.L. _eedt |
|
710 | 1 | _aAxcan Pharma, Inc. | |
999 |
_c591246 _d591246 |